However, the impaired induction of antigen-specific CD8+ T-cells did not impact the outcome regarding tumor growth or survival of the mice in a therapeutic vaccination setting using a B16-OVA melanoma tumor model. The gene discussed is CD8A; the disease is neoplasm.